ArticleAlzheimer's research & therapy2019

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ.

William J Meilandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.